INNOVATION

IMPACT

Innovation at IRIS is measured by real-world impact.

Explore a selection of success cases—projects, technologies, and spin-offs developed by our research community and now creating value for patients, industry, and society.

Choose Resource type

Virmedex Spin-off

Virmedex

Research Group: TecSalut – CG Computer Graphics & Serious Games

WomenUp is a medical device to support women in strengthening their pelvic floor through guided Kegel exercises. It combines EMG technology with a vaginal probe, a wearable transmitter to monitor muscle activity and a mobile app with serious games to make training engaging, and to track progress and personalize treatment.
More info
ABLE Human Motion Spin-off

ABLE Human Motion

Research Group: BIOMEC Biomechanical Engineering Lab

Founded in 2018, ABLE has become a company that develops robotic exoskeletons to improve mobility, independence, and quality of life for people with physical disabilities, especially individuals with paraplegia and stroke survivors. Its solution is a lightweight and affordable exoskeleton that enables users to stand up and walk again.
More info
WomenUp Device

WomenUp

Research Group: BIOART Biosignal Analysis for Rehabilitation and Therapy

WomenUp is a medical device to support women in strengthening their pelvic floor through guided Kegel exercises. It combines EMG technology with a vaginal probe, a wearable transmitter to monitor muscle activity and a mobile app with serious games to make training engaging, and to track progress and personalize treatment.
More info
NovaMeat Product

NovaMeat

Research Group: –

Founded in 2020, Novameat has developed the most realistic plant-based meat ever. The startup has since then worked to refine its prototypes and technology, moving from 3D printing to a microextrusion technology able to create uniquely texturized meat alternatives.
More info
Mimetis Spin-off

Mimetis

Research Group: BBT Biomaterials, Biomechanics and Tissue Engineering

Founded in 2013, Mimetis Biomaterials develops advanced materials and technologies for bone regeneration. Its flagship product is a next-generation injectable calcium phosphate foam with inherent biological properties, capable of supporting and even inducing bone healing. Suitable for minimally invasive procedures, the material hardens in the body and can also serve as a drug delivery system, representing a significant innovation in bone regeneration compared to existing solutions.
More info
RobSurgical Spin-off

RobSurgical

Research Group: GRINS Intelligent Robotics and Systems – With IBEC

Founded in 2012, Rob Surgical company develops surgical robots, starting with the Bitrack system—the first open robotic platform designed to enhance the efficiency and precision of minimally invasive surgery. Built on over ten years of cutting-edge research, Bitrack combines advanced technology, improved usability, and reduced hospital costs to help make precision surgery accessible worldwide.
More info
BrainFocus Spin-off

BrainFocus

Research Group: TBIOCOM-SC Computational Biology and Complex Systems

BrainFocus commercializes technology for the diagnosis of drug-resistant epilepsy. The company enables clinicians to analyze intracranial EEG signals, precisely identify the epileptic focus, and visualize its evolution on a 3D model of the patient’s brain, generating a comprehensive patient report, including automatic localization of the epileptic focus.
More info
CP4C Patent

CP4C

Research Group: BBT Biomaterials, Biomechanics and Tissue Engineering

CP4C is an innovative project developing plasma-treated hydrogels for the treatment of bone cancer. This technology selectively eliminates cancer cells while being fully resorbable, allowing bone regeneration without harming healthy tissue.
More info
EpiGe-App Application

EpiGe-App

Research Group: B2SLab Bioinformatics and Biomedical Signals Lab

A web-based tool to accelerate and improve the automated analysis and classification of medulloblastoma, a malignant brain tumor affecting mainly children and adolescents. The tool enables rapid, precise, and cost-effective identification of molecular subgroups, which is crucial for personalizing treatment and providing more effective, targeted therapies with reduced toxicity.
More info

XARTEC SALUT

XARTEC SALUT

Our network connecting the Catalan healthtech ecosystem — driving research to market & real-world solutions to the society.

Coordinated by the Institute for Research and Innovation in Health (IRIS) at the Universitat Politècnica de Catalunya, Xartec Salut is Catalonia’s leading R+D+I network in health technologies.

Created in 2021, with the support of the AGAUR, Generalitat de Catalunya and the European Regional Development Fund; the network aims to transform scientific knowledge into real-world solutions capable of improving people’s lives.

Currently comprising 122 research groups from 31 institutions, with the collaboration of 19 partner organisations.

The network promotes and drives the valorisation and transfer of medical technologies by fostering integration and collaboration among researchers, healthcare centres, companies, patient associations and public administrations, with the ultimate goal of generating social and economic impact within the healthcare system.

IRIS not only promoted the creation of Xartec Salut but also leads its operational and strategic coordination, providing structural support, specialised expertise, and a collaborative environment that strengthens Catalonia’s health innovation landscape.

Highlights

122
Research Groups
31
Institutions
19
Partners
+50
Accelerated
Projects
+15
Spin-offs
Created
+300
Identified Technologies
in the Network
+250
Professionals Trained
+30
Licensed Patents
+70
Events

What Xartec Salut Offers

Expert support in technology transfer

Including key instruments and services that guide the journey from research to market, bringing innovative solutions to patients, companies, and society.

Training and entrepreneurship programmes

Specialised learning tools and collaborations that foster technology transfer, spin-off creation, and talent-driven innovation.

Direct collaboration with companies and investors

Through strategic events and programmes linking network members with leading industry partners.

Strategic visibility of emerging technologies

With an active catalogue of 300+ solutions and ongoing promotion and communication efforts.

A vibrant collaborative community

That connects research groups, industry, healthcare centres, and institutions to generate synergies and disruptive projects.

Follow Xartex Salut

Visit their website and stay connected on social media.

Go to Xartex Salut